DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
+3.14%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$2.35B
AUM Growth
+$2.35B
(+2.5%)
Cap. Flow
+$245M
Cap. Flow
% of AUM
10.43%
Top 10 Holdings %
Top 10 Hldgs %
48.76%
Holding
74
New
14
Increased
12
Reduced
15
Closed
17
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$92.1M |
| 2 |
Alkermes
ALKS
|
$84.6M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$66.3M |
| 4 |
Structure Therapeutics
GPCR
|
$63M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$58.2M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$85.5M |
| 2 |
Sarepta Therapeutics
SRPT
|
$68.4M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$56.9M |
| 4 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$36.8M |
| 5 |
Immunovant
IMVT
|
$35.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
26
Autolus Therapeutics
AUTL
$383M
| $27.6M | 1.13% |
15,000,000
| – | – |
|
27
89bio
ETNB
$1.37B
| $27.4M | 1.13% |
1,800,000
-2,050,000
| -53% | -$31.2M |
|
28
Dyne Therapeutics
DYN
$1.92B
| $26.9M | 1.1% |
2,334,633
-349,567
| -13% | -$4.03M |
|
29
Repare Therapeutics
RPTX
$73.9M
| $26.8M | 1.1% |
2,727,606
| – | – |
|
30
Nurix Therapeutics
NRIX
$723M
| $26.6M | 1.09% |
2,997,830
+731,261
| +32% | +$6.49M |
|
31
Intellia Therapeutics
NTLA
$1.26B
| $26.3M | 1.08% |
704,533
+4,533
| +0.6% | +$169K |
|
32
Astria Therapeutics
ATXS
$394M
| $24.2M | 0.99% |
1,816,531
| – | – |
|
|
DCPH
33
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $21.1M | 0.87% |
+1,363,201
| New | +$21.1M |
|
34
Edgewise Therapeutics
EWTX
$1.54B
| $20.5M | 0.84% |
3,068,259
-306,135
| -9% | -$2.04M |
|
|
VIGL
35
DELISTED
Vigil Neuroscience
VIGL
| $19.8M | 0.81% |
2,025,137
-79,037
| -4% | -$774K |
|
|
INZY
36
DELISTED
Inozyme Pharma
INZY
| $18.6M | 0.76% |
3,250,000
| – | – |
|
37
uniQure
QURE
$954M
| $17.4M | 0.72% |
+865,767
| New | +$17.4M |
|
|
PNT
38
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $17M | 0.7% |
+2,345,073
| New | +$17M |
|
39
Acumen Pharmaceuticals
ABOS
$84.2M
| $16M | 0.66% |
3,952,000
| – | – |
|
|
ALLK
40
DELISTED
Allakos
ALLK
| $16M | 0.66% |
3,585,000
-1,314,179
| -27% | -$5.85M |
|
41
Aclaris Therapeutics
ACRS
$223M
| $13.8M | 0.57% |
+1,708,971
| New | +$13.8M |
|
42
Nuvation Bio
NUVB
$1.08B
| $12.8M | 0.53% |
7,720,688
-500,500
| -6% | -$831K |
|
|
SLN
43
Silence Therapeutics
SLN
$237M
| $12.1M | 0.5% |
1,951,580
| – | – |
|
44
RAPT Therapeutics
RAPT
$187M
| $10.5M | 0.43% |
571,233
-733,707
| -56% | -$13.5M |
|
|
JNCE
45
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $7.88M | 0.32% |
4,259,653
| – | – |
|
46
Relmada Therapeutics
RLMD
$48.8M
| $6.41M | 0.26% |
2,837,818
| – | – |
|
|
ORTX
47
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $6.27M | 0.26% |
+1,166,670
| New | +$6.27M |
|
48
Heron Therapeutics
HRTX
$204M
| $4.88M | 0.2% |
3,234,722
-3,262,254
| -50% | -$4.93M |
|
49
Nkarta
NKTX
$149M
| $4.81M | 0.2% |
1,354,200
| – | – |
|
50
GH Research
GHRS
$870M
| $3.99M | 0.16% |
499,400
| – | – |
|